Head of Chemistry and IP @ (July 2022 - September 2023)
COO @ (October 2018 - June 2022)
CEO @ (March 2016 - September 2018)
External Consultant @ (November 2014 - May 2016)
Senior Consultant @ Zelibra AB (February 2011 - November 2014)
Principal Scientist @ (January 2007 - January 2010)
Director Medicinal Chemistry @ Biolipox (January 2002 - January 2007)
Section Head, Medicinal Chemistry @ Karo Bio (January 1999 - January 2002)
Group leader @ (January 1997 - January 1999)
Research Scientist @ Astra Pain Control (January 1991 - January 1997)
Benjamin Pelcman Education
Dartmouth College
Post Doc (Organic Chemstry)
1988-1989
Västertorps Gymnasium
KTH Royal Institute of Technology
Doctor of Philosophy (PhD) (Organic Chemistry)
Benjamin Pelcman Skills
Life Sciences
Medicinal Chemistry
Drug Discovery
Organic Synthesis
Pharmaceutical Industry
Drug Development
R&D
Technology Transfer
Leadership
Program Management
Marketing
Microsoft Excel
Research
Strategy
Benjamin Pelcman Summary
Benjamin Pelcman, based in Stockholm, SE, is currently a CEO, Owner at BeePCo AB. Benjamin Pelcman brings experience from previous roles at MyCural Therapeutics and Atrogi. Benjamin Pelcman holds a 1988 - 1989 Post Doc in Organic Chemstry @ Dartmouth College. With a robust skill set that includes Life Sciences, Medicinal Chemistry, Drug Discovery, Organic Synthesis, Pharmaceutical Industry and more. Benjamin Pelcman has 2 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Benjamin Pelcman?
Find contact details for 700 million professionals.